Get started
Author

Iben Lyskjær

Observed names: Heimann, Iben Lyskjær, I. Lyskjær, I.L. Heimann, Lyskjær, Iben
ORCID: 0000-0003-3446-1182
Observed ORCID: 0000-0003-3446-1182
OpenAlex ID: A5000813076
Sarcoma classification by DNA methylation profiling
2021 · Christian Koelsche, Daniel Schrimpf, et al. · Nature Communications · 559
miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells
2016 · Mads Heilskov Rasmussen, Iben Lyskjær, et al. · Nature Communications · 93
PDF
DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘ DKFZ Sarcoma Classifier’
2021 · Iben Lyskjær, Solange De Noon, et al. · The Journal of Pathology Clinical Research · 73
PDF
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
2024 · Laura Iisager, Johanne Ahrenfeldt, et al. · BMC Cancer · 55
PDF
Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic
2023 · Iben Lyskjær, Laura Iisager, et al. · Clinical Cancer Research · 44
PDF
Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer
2019 · Iben Lyskjær, Camilla Skovhus Kronborg, et al. · Scientific Reports · 43
PDF
Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA
2022 · Iben Lyskjær, Neesha Kara, et al. · European Journal of Cancer · 42
PDF
H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours
2020 · Iben Lyskjær, Daniel Lindsay, et al. · The Journal of Pathology · 41
A genetically inducible porcine model of intestinal cancer
2017 · Morten M. Callesen, Sigrid S. Árnadóttir, et al. · Molecular Oncology · 41
PDF
MYC amplifications are common events in childhood osteosarcoma
2021 · Solange De Noon, Jannat Ijaz, et al. · The Journal of Pathology Clinical Research · 40
PDF
Drivers underpinning the malignant transformation of giant cell tumour of bone
2020 · Matthew W Fittall, Iben Lyskjær, et al. · The Journal of Pathology · 36
PDF
A genetic model for central chondrosarcoma evolution correlates with patient outcome
2022 · William Cross, Iben Lyskjær, et al. · Genome Medicine · 33
PDF
Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer
2023 · Kezhong Chen, Guannan Kang, et al. · BMC Medicine · 32
PDF
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
2021 · Iben Lyskjær, Christopher Davies, et al. · Molecular Oncology · 18
PDF
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma
2025 · Jesper Jespersen, Cecilie Lindgaard, et al. · Nature Reviews Urology · 15
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
2024 · Nadia Øgaard, Sarah Østrup Jensen, et al. · British Journal of Cancer · 13
PDF
DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection
2023 · Mikkel H. Christensen, Simon Drue, et al. · Genome biology · 13
PDF
Subclassification of epithelioid sarcoma with potential therapeutic impact
2023 · Simon Haefliger, Olga Chervova, et al. · The Journal of Pathology · 12
PDF
KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer – an observational trial. Study protocol
2024 · Laura Iisager, Johanne Ahrenfeldt, et al. · Acta Oncologica · 9
PDF
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma
2025 · William Cross, Iben Lyskjær, et al. · Genome biology · 7
PDF
Putting a Brake on Stress Signaling: miR-625-3p as a Biomarker for Choice of Therapy in Colorectal Cancer
2016 · Iben Lyskjær, Mads H Rasmussen, et al. · Epigenomics · 7
PDF
Trends in kidney cancer: exploring the impact of sex and age on stage of disease, and prognosis during the past three decades in Denmark—a DaRenCa study
2025 · Johanne Ahrenfeldt, Jesper Jespersen, et al. · European Journal of Epidemiology · 5
PDF
Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry Study
2026 · Johanne Ahrenfeldt, Jesper Jespersen, et al. · Radiology · 3
Epigenetic age acceleration is a distinctive trait of epithelioid sarcoma with potential therapeutic implications
2024 · Simon Haefliger, Olga Chervova, et al. · GeroScience · 3
Preoperative positive ctDNA analysis is associated with the tumor microenvironment, and the risk of recurrence in non-metastatic colorectal cancer
2026 · Mikail Gögenur, Lukas Balsevicius, et al. · npj Precision Oncology · 2
PDF
Works count: 61
Citation count: 1,243
H-index: 15
I10-index: 18
Year
Topic
Type